Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
172M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
85.5M
-
Shares change
-
-2.21M
-
Total reported value, excl. options
-
$2.96B
-
Value change
-
-$171M
-
Number of buys
-
91
-
Number of sells
-
-32
-
Price
-
$34.57
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q1 2021
141 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.5M shares
of 172M outstanding shares and own 49.79% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27.9M shares), FMR LLC (5.83M shares), VANGUARD GROUP INC (4.05M shares), BlackRock Inc. (3.8M shares), EcoR1 Capital, LLC (3.43M shares), Casdin Capital, LLC (3.38M shares), BVF INC/IL (2.87M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.54M shares), Foresite Capital Management IV, LLC (2.14M shares), and GILDER GAGNON HOWE & CO LLC (2.02M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.